🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis (MS) is a chronic, inflammatory and disabling disease of...
Status
Completed
Location
Neurociencia Clínica Integral
Start Date
2023-08-01
Trial ID
NCT07680738
The goal of this study is to use non-invasive transcranial direct current s...
Status
Unknown
Location
University of Arizona
Start Date
2025-01-15
Trial ID
NCT04934371
Treatments Being Tested
Transcranial direct current stimulation (tDCS) is a non-invasive neuromodul...
Status
Unknown
Location
Corporación de Rehabilitación Club de Leones Cruz del Sur
Start Date
2019-12-01
Trial ID
NCT04245059
Treatments Being Tested
The purpose of the proposed study is to broaden our understanding on the ne...
Status
Recruiting
Location
University of Manitoba
Start Date
2023-07-01
Trial ID
NCT05959551
Treatments Being Tested
This study's goal is to use non-invasive brain stimulation (NBS) techniques...
Status
Recruiting
Location
University of Arizona
Start Date
2021-08-30
Trial ID
NCT04920318
Treatments Being Tested
The goal of this clinical trial is to learn if an integrated protocol using...
Status
Recruiting
Location
Department of Psychology, University of Campania "Luigi Vanvitelli"
Start Date
2024-10-01
Trial ID
NCT06668610
The goal of this clinical trial is to evaluate whether the application of o...
Status
Recruiting
Location
The Catholic University of Korea, Bucheon St. Mary's Hospital
Start Date
2024-04-22
Trial ID
NCT06305949
The purpose of this study is to determine whether TDCS is an effective prop...
Status
Completed
Location
Grenoble University Hospital
Start Date
2014-05-05
Trial ID
NCT02120326
The majority of transcranial direct current stimulation (tDCS) studies have...
Status
Completed
Location
University of Iowa
Start Date
2020-10-01
Trial ID
NCT04471805
MCI is considered an intermediate stage between normal cognitive aging and ...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05584748
Treatments Being Tested